Researchers regrow boy’s skin cells from stem cells – Johns Hopkins News-Letter
|
Researchers regrow boy’s skin cells from stem cells
Johns Hopkins News-Letter Stem cells are special cells in our body that have the potential to develop into many different types of cells during proliferation. A stem cell divides by producing a new cell with the potential either to remain a stem cell or to become a cell with a … |
Reuters |
$1 million price tag in spotlight as gene therapy becomes reality
Reuters O). Spark’s Chief Financial Officer Stephen Webster said on Thursday that gene therapy was upending conventional thinking by offering a one-time cure, rather than years of repeat prescriptions, but health systems were struggling to keep pace. “Gene … Brainstorm Health: Gene Therapy Cost, Roche Drug Approval, Medicaid Work RequirementsFortune |
Gizmodo |
The FDA Wants To Bring Gene Therapies to Market Much Faster
Gizmodo In August, the Food and Drug Administration approved a treatment that genetically modifies a patient’s blood cells in order to treat childhood leukemia, a major first that paved the way for an era of FDA-sanctioned human gene modification. Since then … |
Gizmodo |
The FDA Wants To Bring Gene Therapies to Market Much Faster
Gizmodo In August, the Food and Drug Administration approved a treatment that genetically modifies a patient’s blood cells in order to treat childhood leukemia, a major first that paved the way for an era of FDA-sanctioned human gene modification. Since then … |
EurekAlert (press release) |
Seattle Children’s opens first pediatric CAR T-Cell trial targeting CD22 and CD19 proteins
EurekAlert (press release) Seattle Children’s has opened the first chimeric antigen receptor (CAR) T-cell immunotherapy trial in the U.S. for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia (ALL) that will simultaneously … New immunotherapy study aims to prevent children with leukemia from relapsingGeekWire |
|
In the Pipeline-Cerebral Adrenoleukodystrophy: Gene Therapy Halts Progression of Cerebral ALD
LWW Journals KANSAS CITY, MO—Fifteen of 17 boys with cerebral adrenoleukodystrophy (ALD) are doing well after receiving a novel gene therapy, scientists at Massachusetts General Hospital and Boston Children’s Hospital reported at the Child Neurology Society … |